- AU$19.27m
- AU$15.86m
- AU$0.27m
Brief: Opyl Seeks Trading Halt
Brief: Opyl Ltd Says Saurabh Jain Joins Co As Interim CEO
Brief: Opyl Says Michelle Gallaher Has Permanently Stepped Down As CEO
Australia's Opyl eyes best day in more than 16 months on deal with Bristol-Myers Squibb
Brief: Opyl Agreement And New Clinical Trial Recruitment Contracts With Bristol Myers Squibb
Brief: Opyl Ltd Seeks Trading Halt
Brief: Opyl Says Signs Two Partnerships With Neuroendocrine Cancer Australia And Pancare Foundation
Australia Stock Exchange release from OPYL : Opyl receives $361K R&D tax refund
Australia Stock Exchange release from OPYL : Change of Director's Interest Notice - J Chick
Australia Stock Exchange release from OPYL : Appendix 4D & Half Year Results
Australia Stock Exchange release from OPYL : PRE_NR Ends: 10:21:46
Australia Stock Exchange release from OPYL : Opyl - Clarification Statement to Appendix 4C
Australia Stock Exchange release from OPYL : Change of Director's Interest Notice - M Ziirsen
Australia Stock Exchange release from OPYL : Opyl - Business Update & Appendix 4C
Australia Stock Exchange release from OPYL : PRE_NR Ends: 09:44:48
Australia Stock Exchange release from OPYL : Change of Director's Interest Notice - Dr Megan Robertson
Australia Stock Exchange release from OPYL : Opyl - Shareholder End of Year Update
Australia Stock Exchange release from OPYL : Opyl - 2021 Annual Report to shareholders
Australia Stock Exchange release from OPYL : Opyl - Change of Director's Interest Notice - Dr J Chick